花生四烯酸代谢网络研究:从关键酶的单靶标抑制剂到多靶标抑制剂

被引:18
作者
刘莹
陈政
尚尔昌
杨坤
位灯国
周璐
蒋小蕗
贺冲
来鲁华
机构
[1] 北京大学化学与分子工程学院,北京分子科学国家实验室(筹),分子动态与稳态结构国家重点实验室
关键词
花生四烯酸代谢网络; 关键酶; 单靶标抑制剂; 多靶标抑制剂;
D O I
10.16438/j.0513-4870.2009.03.012
中图分类号
R91 [药物基础科学];
学科分类号
1007 ;
摘要
炎症引发的疾病是人类常见的免疫系统疾病,医药市场对抗炎药物的需求量极大。花生四烯酸代谢网络是产生炎症介质的主要网络,网络中的一些蛋白质已成为抗炎药物设计的重要靶标,但这些单靶标药物不能很好地控制网络的平衡,同时容易引起副作用。大多数炎症引发的疾病是由多级联炎症代谢共同影响的结果,为了更好地治疗这类由多个药靶参与调控的复杂疾病,发展针对花生四烯酸代谢网络的多靶标药物具有迫切性。本文综述花生四烯酸代谢网络的关键靶标(如磷脂酶A2、环氧合酶、5-脂氧合酶和白三烯A4水解酶等)的特异性抑制剂和多靶标抑制剂研究进展。
引用
收藏
页码:231 / 241
页数:11
相关论文
共 15 条
[1]   Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase [J].
Ye, Bin ;
Bauman, John ;
Chen, Ming ;
Davey, David ;
Khim, Seock-Kyu ;
King, Beverly ;
Kirkland, Thomas ;
Kochanny, Monica ;
Liang, Amy ;
Lentz, Dao ;
Maya, Karen ;
Mendoza, Lisa ;
Phillips, Gary ;
Selchau, Victor ;
Schlyer, Sabine ;
Tseng, Jih-Lie ;
Wei, Robert G. ;
Ye, Hong ;
Parkinson, John ;
Guilford, William J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) :3891-3894
[2]   Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E2-independent mechanisms [J].
Deasy, B. M. ;
O'Sullivan-Coyne, G. ;
O'Donovan, T. R. ;
Mckenna, S. L. ;
O'Sullivan, G. C. .
CANCER LETTERS, 2007, 256 (02) :246-258
[3]  
1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A 2 α: Bioisosteric replacement of the carboxylic acid and carboxamide moiety[J] . Mark Hess,Alwine Schulze Elfringhoff,Matthias Lehr.Bioorganic & Medicinal Chemistry . 2007 (8)
[4]  
COX-2 controversy: where are we and where do we go from here?[J] . Dinesh Khanna,Puja P Khanna,Daniel E Furst.Inflammopharmacology . 2005 (4)
[5]   Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886 [J].
Riendeau, D ;
Aspiotis, R ;
Ethier, D ;
Gareau, Y ;
Grimm, EL ;
Guay, J ;
Guiral, S ;
Juteau, H ;
Mancini, JA ;
Méthot, N ;
Rubin, J ;
Friesen, RW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (14) :3352-3355
[6]  
The efficiency of multi-target drugs: the network approach might help drug design[J] . Péter Csermely,Vilmos ágoston,Sándor Pongor.Trends in Pharmacological Sciences . 2005 (4)
[7]  
Strong links are important, but weak links stabilize them[J] . Peter Csermely.Trends in Biochemical Sciences . 2004 (7)
[8]  
Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors[J] . Giovanni de Gaetano,Maria Benedetta Donati,Chiara Cerletti.Trends in Pharmacological Sciences . 2003 (5)
[9]  
Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1 H -dihydropyrrolizine type[J] . Holger Ulbrich,Bernd Fiebich,Gerd Dannhardt.European Journal of Medicinal Chemistry . 2002 (12)
[10]   Novel 3-dodecanoylindole-2-carboxylic acid inhibitors of cytosolic phospholipase A2 [J].
Lehr, M ;
Klimt, M ;
Elfringhoff, AS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (19) :2569-2572